Dr. John Shufeldt, MD, founder of Xcellerant Ventures, Netcare Urgent Care Centers, and multiple other successful ventures, has partnered with Kendric Speagle, a leader in drug development who has brought numerous new pharmaceuticals to market through VivaMed.
Together, they’ve created VIVO—a “Robin Hood”-style platform for early-stage drug investments.
VIVO empowers everyday individuals to invest in early-stage pharmaceuticals, disrupting traditional big pharma’s control and reducing the likelihood of promising drugs being shelved in favor of inferior treatments.